Bupathi, M.; Garmezy, B.; Lattanzi, M.; Kieler, M.; Ibrahim, N.; Perk, T.G.; Weisman, A.J.; Perlman, S.B.
Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT. J. Clin. Med. 2024, 13, 6168.
https://doi.org/10.3390/jcm13206168
AMA Style
Bupathi M, Garmezy B, Lattanzi M, Kieler M, Ibrahim N, Perk TG, Weisman AJ, Perlman SB.
Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT. Journal of Clinical Medicine. 2024; 13(20):6168.
https://doi.org/10.3390/jcm13206168
Chicago/Turabian Style
Bupathi, Manojkumar, Benjamin Garmezy, Michael Lattanzi, Minnie Kieler, Nevein Ibrahim, Timothy G. Perk, Amy J. Weisman, and Scott B. Perlman.
2024. "Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT" Journal of Clinical Medicine 13, no. 20: 6168.
https://doi.org/10.3390/jcm13206168
APA Style
Bupathi, M., Garmezy, B., Lattanzi, M., Kieler, M., Ibrahim, N., Perk, T. G., Weisman, A. J., & Perlman, S. B.
(2024). Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT. Journal of Clinical Medicine, 13(20), 6168.
https://doi.org/10.3390/jcm13206168
